Table 1.
Tuberculosis (TB) clinical and microbiological features
| Study | Period | Country | Patient number | Symptoms length (days) | Concomitant pulmonary TB | Success | Microbiological diagnosis | Positive smear | Sensitive strains |
|---|---|---|---|---|---|---|---|---|---|
| Weng et al. [18] | 1998–2007 | Taiwan | 38 | 60 (3–720) | 12/38 (32%) | 35/38 (92%) | 24/38 (63%) | 22/38 (58%) | 18/38 (75%) |
| Nagashiman et al. [17] | 1956–2005 | Japón | 31 | – | – | – | 31/121 (25.6%) | – | – |
| Cormican et al. [2] | 1999–2004 | UK | 23 | 330 (45–1080) | 3/23 (14%) | 13/23 (56.3%) | 16/23 (76%) | 15 (75%) | 69% |
| AlOthman et al. [13] | 1985–1998 | Arabia Saudí | 69 | – | – | 63 (91%) | 57/69 (87.7%) | 20/57 (35%) | |
| Polley et al. [1] | 2001–2006 | Cape Town | 16 | – | – | 11 (68.75%) | 8 (15) | 4/14 (28.6%) | 6/8 (75%) |
| Pertuiset et al. [28] | 1980–1994 | Paris | 103 | – | – | – | 85/103 (83%) | 103 (100%) |
A dash (-) indicates no available data